Related Articles
Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma
Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway
Inhibition of aerobic glycolysis alleviates sepsis‑induced acute kidney injury by promoting lactate/Sirtuin 3/AMPK‑regulated autophagy
Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells
Silencing of <em>ISLR</em> inhibits tumour progression and glycolysis by inactivating the IL‑6/JAK/STAT3 pathway in non‑small cell lung cancer